SCHEMBL17975331

SCHEMBL17975331

CCc1cc(=O)nc(NC(=N)Nc2ccc(OC)cc2)[nH]1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.41
POLB P06746 3/20 0.41
LMNA P02545 1/20 0.41
KMT2A Q03164 4/20 0.40
ALDH1A1 P00352 3/20 0.40
FPR2 P25090 2/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 4/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
FPR1 P21462 1/20 0.38
MEN1 O00255 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CASP3 P42574 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17988277 0.90 POLB (0.41) SMN1; SMN2POLBLMNAKMT2AALDH1A1
SCHEMBL17975333 0.88 HPGD (0.43) SMN1; SMN2POLBLMNAKMT2AALDH1A1
SCHEMBL17988276 0.78 KDR (0.43) SMN1; SMN2POLBLMNAKMT2AALDH1A1
SCHEMBL17975332 0.77 MAPT (0.45) SMN1; SMN2POLBLMNAKMT2AALDH1A1
SCHEMBL14542713 0.75 POLB (0.64) SMN1; SMN2POLBLMNAKMT2AALDH1A1
SCHEMBL13919668 0.73 HTT (0.43) SMN1; SMN2POLBLMNAKMT2AALDH1A1
SCHEMBL8741847 0.71 NPC1 (0.63) SMN1; SMN2KMT2AALDH1A1TP53MAPT
SCHEMBL13919665 0.69 MAPT (0.40) SMN1; SMN2POLBLMNAKMT2AALDH1A1
SCHEMBL14598238 0.68 XDH (0.39) TP53MAPTNPC1GAA
SCHEMBL13265665 0.67 POLB (0.62) SMN1; SMN2POLBLMNAKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160374997-A1 ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2016-12-29 US disclosed
US-20160220510-A1 ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2016-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160374997-A1 ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS AARS1, EPRS1, EEF1G SMN1; SMN2 4205/4885POLB 1612/4885LMNA 4707/4885
US-20160220510-A1 ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS AARS1, EPRS1, EEF1G SMN1; SMN2 4205/4885POLB 1612/4885LMNA 4707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.